Insilico Medicine

Latest news and articles about Insilico Medicine from NEX English

Eli Lilly Partners with Insilico to Develop AI-Designed Drugs

Eli Lilly has announced a new partnership with Insilico Medicine aimed at developing drugs entirely designed by artificial intelligence. The deal, valued at approximately <strong>$2.75 billion</strong>, will enhance the company's efforts in discovering new treatments for various diseases.

Expand partnership worth $2.75 billion to enhance drug discovery

Insilico Medicine has announced an expansion of its partnership with Eli Lilly in a deal valued at $2.75 billion, focusing on AI-driven drug discovery. Eli Lilly will leverage Insilico's AI engine to gain exclusive licenses for developing new treatments.